Solid Biosciences (SLDB) Interest Coverage Ratio (2023 - 2025)
Quarterly results put Interest Coverage Ratio at 9880.6 for Q4 2025, down 1757.44% from a year ago — trailing twelve months through Mar 2026 was 724.95 (up 258.77% YoY), and the annual figure for FY2025 was 882.79, up 331.37%.
Solid Biosciences has reported Interest Coverage Ratio over the past 3 years, most recently at 9880.6 for Q4 2025.
- Interest Coverage Ratio reached 9880.6 in Q4 2025 per SLDB's latest filing, down from 143.03 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 143.03 in Q3 2025 and bottomed at 9880.6 in Q4 2025.
- Median Interest Coverage Ratio over the past 3 years was 299.27 (2024), compared with a mean of 1127.17.
- Peak annual rise in Interest Coverage Ratio hit 133.34% in 2025, while the deepest fall reached 1757.44% in 2025.
- Over 3 years, Interest Coverage Ratio stood at 220.45 in 2023, then tumbled by 141.31% to 531.95 in 2024, then tumbled by 1757.44% to 9880.6 in 2025.
- Business Quant data shows Interest Coverage Ratio for SLDB at 9880.6 in Q4 2025, 143.03 in Q3 2025, and 694.88 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 49.84 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 11.50 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.88 |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,880.60 |
| Sep 30, 2025 | 143.03 |
| Jun 30, 2025 | -694.88 |
| Mar 31, 2025 | -589.00 |
| Dec 31, 2024 | -531.95 |
| Sep 30, 2024 | -429.05 |
| Jun 30, 2024 | -315.77 |
| Mar 31, 2024 | -282.76 |
| Dec 31, 2023 | -220.45 |
| Sep 30, 2023 | -218.06 |
| Jun 30, 2023 | -241.83 |
| Mar 31, 2023 | -264.71 |